Tag
Dr. Matthew Zirwas retracts his earlier dismissal of the Midjourney ultrasound scanner, acknowledging that if it is high-resolution, harmless, inexpensive, and convenient, frequent screening could overcome historical pitfalls of unnecessary invasive procedures, though he emphasizes that data is needed to confirm benefit.
A study from King's College London reveals that hospitals and universities are conducting late-stage clinical trials for repurposing generic drugs at less than 10% of pharmaceutical companies' costs, offering affordable treatments for conditions like blindness, cancer prevention, and Covid.